Muscle strength and incidence of depression and anxiety: findings from the UK Biobank prospective cohort study.


Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
08 2022
Historique:
revised: 02 02 2022
received: 03 08 2021
accepted: 03 02 2022
pubmed: 10 6 2022
medline: 26 8 2022
entrez: 9 6 2022
Statut: ppublish

Résumé

Depression and anxiety are the leading mental health problems worldwide; depression is ranked as the leading cause of global disability with anxiety disorders ranked sixth. Preventive strategies based on the identification of modifiable factors merit exploration. The aim of the present study was to investigate the associations of handgrip strength (HGS) with incident depression and anxiety and to explore how these associations differ by socio-demographic, lifestyle, and health-related factors. The analytic sample comprised 162 167 participants (55% women), aged 38-70 years, from the UK Biobank prospective cohort study. HGS was assessed at baseline using dynamometry. Depression and anxiety were extracted from primary care and hospital admission records. Cox proportional models were applied, with a 2 year landmark analysis, to investigate the associations between HGS and incident depression and anxiety. Of the 162 167 participants included, 5462 (3.4%) developed depression and 6614 (4.1%) anxiety, over a median follow-up period of 10.0 years (inter-quartile range: 9.3-10.8) for depression and 9.9 (inter-quartile range: 9.0-10.8) for anxiety. In the fully adjusted model, a 5 kg lower HGS was associated with a 7% (HR: 1.07 [95% CI: 1.05, 1.10]; P < 0.001) and 8% (HR: 1.08 [95% CI: 1.06, 1.10]; P < 0.001) higher risk of depression and anxiety, respectively. Compared with participants in the sex and age-specific highest tertiles of HGS, those in the medium and lowest tertiles had an 11% (HR: 1.11 [95% CI: 1.04, 1.19]; P = 0.002) and 24% (HR: 1.24 [95% CI: 1.16, 1.33]; P < 0.001) higher risk of depression and 13% (HR: 1.13 [95% CI: 1.06, 1.20]; P < 0.001) and 27% (HR: 1.27 [95% CI: 1.19, 1.35]; P < 0.001) higher risk of anxiety, respectively. The association of HGS with depression was stronger among participants with average or brisk walking pace (vs. slow walking pace; P Handgrip strength was inversely associated with incident depression and anxiety. Because HGS is a simple, non-invasive, and inexpensive measure, it could be easily used in clinical practice to stratify patients and identify those at elevated risk of mental health problems. However, future research should assess if resistance training aimed at increasing HGS can prevent the occurrence of mental health conditions.

Sections du résumé

BACKGROUND
Depression and anxiety are the leading mental health problems worldwide; depression is ranked as the leading cause of global disability with anxiety disorders ranked sixth. Preventive strategies based on the identification of modifiable factors merit exploration. The aim of the present study was to investigate the associations of handgrip strength (HGS) with incident depression and anxiety and to explore how these associations differ by socio-demographic, lifestyle, and health-related factors.
METHODS
The analytic sample comprised 162 167 participants (55% women), aged 38-70 years, from the UK Biobank prospective cohort study. HGS was assessed at baseline using dynamometry. Depression and anxiety were extracted from primary care and hospital admission records. Cox proportional models were applied, with a 2 year landmark analysis, to investigate the associations between HGS and incident depression and anxiety.
RESULTS
Of the 162 167 participants included, 5462 (3.4%) developed depression and 6614 (4.1%) anxiety, over a median follow-up period of 10.0 years (inter-quartile range: 9.3-10.8) for depression and 9.9 (inter-quartile range: 9.0-10.8) for anxiety. In the fully adjusted model, a 5 kg lower HGS was associated with a 7% (HR: 1.07 [95% CI: 1.05, 1.10]; P < 0.001) and 8% (HR: 1.08 [95% CI: 1.06, 1.10]; P < 0.001) higher risk of depression and anxiety, respectively. Compared with participants in the sex and age-specific highest tertiles of HGS, those in the medium and lowest tertiles had an 11% (HR: 1.11 [95% CI: 1.04, 1.19]; P = 0.002) and 24% (HR: 1.24 [95% CI: 1.16, 1.33]; P < 0.001) higher risk of depression and 13% (HR: 1.13 [95% CI: 1.06, 1.20]; P < 0.001) and 27% (HR: 1.27 [95% CI: 1.19, 1.35]; P < 0.001) higher risk of anxiety, respectively. The association of HGS with depression was stronger among participants with average or brisk walking pace (vs. slow walking pace; P
CONCLUSIONS
Handgrip strength was inversely associated with incident depression and anxiety. Because HGS is a simple, non-invasive, and inexpensive measure, it could be easily used in clinical practice to stratify patients and identify those at elevated risk of mental health problems. However, future research should assess if resistance training aimed at increasing HGS can prevent the occurrence of mental health conditions.

Identifiants

pubmed: 35678014
doi: 10.1002/jcsm.12963
pmc: PMC9398224
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1983-1994

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health [UK]
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Welsh Assembly Government
Organisme : Ramon y Cajal
ID : RYC-2016-20546
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : IJC2018-038008-I
Organisme : Ministerio de Economía y Competitividad
ID : RTI2018-095284-J-100

Informations de copyright

© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

J Affect Disord. 2012 Feb;136(3):828-32
pubmed: 22036794
Exp Gerontol. 2018 Jul 15;108:87-91
pubmed: 29627421
Wien Klin Wochenschr. 2019 Jun;131(11-12):255-264
pubmed: 30963333
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58
pubmed: 24737557
BMC Med. 2018 Jul 20;16(1):112
pubmed: 30025524
Sports Med. 2017 Feb;47(2):277-293
pubmed: 27260682
Psychosom Med. 2020 Jan;82(1):39-46
pubmed: 31702599
Curr Sports Med Rep. 2019 Aug;18(8):299-304
pubmed: 31389872
Psychol Med. 2017 Sep;47(12):2107-2117
pubmed: 28374652
BMC Med. 2019 Apr 10;17(1):74
pubmed: 30967141
J Affect Disord. 2019 Aug 1;255:136-141
pubmed: 31150943
Eur J Public Health. 2020 Aug 1;30(4):767-777
pubmed: 31302703
Neuropsychobiology. 2013;67(2):61-8
pubmed: 23295766
Lancet. 2012 Mar 31;379(9822):1173-4
pubmed: 22463865
Early Interv Psychiatry. 2019 Dec;13(6):1310-1318
pubmed: 30666789
BMJ. 2020 Feb 12;368:m131
pubmed: 32051121
Can J Psychiatry. 2010 Mar;55(3):126-35
pubmed: 20370962
BMJ. 2018 May 8;361:k1651
pubmed: 29739772
Neurosci Biobehav Rev. 2019 Dec;107:525-539
pubmed: 31586447
Age Ageing. 2015 Jul;44(4):592-8
pubmed: 25712514
Acta Radiol. 2017 Mar;58(3):344-352
pubmed: 27235455
J Am Geriatr Soc. 2017 Mar;65(3):526-532
pubmed: 28102890
Int J Obes (Lond). 2015 Dec;39(12):1717-20
pubmed: 26122029
J Affect Disord. 2019 Oct 1;257:748-757
pubmed: 31398589
Mayo Clin Proc. 2020 May;95(5):879-888
pubmed: 32299669
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
J Cachexia Sarcopenia Muscle. 2022 Aug;13(4):1983-1994
pubmed: 35678014
Phys Ther. 2017 Jun 01;97(6):659-668
pubmed: 28201628
Int J Biostat. 2009 Jan 07;5(1):Article 2
pubmed: 20231865
Exp Gerontol. 2018 Apr;104:147-152
pubmed: 29454029
Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80
pubmed: 18752720
BMC Med. 2020 Nov 11;18(1):303
pubmed: 33172457
J Affect Disord. 2019 Jan 15;243:448-454
pubmed: 30273883
Exp Gerontol. 2020 Dec;142:111116
pubmed: 33086078
Aging Ment Health. 2021 Mar;25(3):468-475
pubmed: 31829040
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
J Affect Disord. 2019 Feb 15;245:371-376
pubmed: 30423464
Ageing Res Rev. 2020 Mar;58:100999
pubmed: 31837462
Sports Med. 2017 Dec;47(12):2521-2532
pubmed: 28819746
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Acta Psychiatr Scand. 2017 May;135(5):373-387
pubmed: 28122130
J Affect Disord. 2020 May 15;269:12-17
pubmed: 32217338

Auteurs

Verónica Cabanas-Sánchez (V)

IMDEA Food Institute, CEI UAM+CSIC, Madrid, Spain.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Irene Esteban-Cornejo (I)

PROFITH 'PROmoting FITness and Health through physical activity' Research Group, Sport and Health University Research Institute (iMUDS), Department of Physical Education and Sports, Faculty of Sport Sciences, University of Granada, Granada, Spain.

Solange Parra-Soto (S)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Fanny Petermann-Rocha (F)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.

Stuart R Gray (SR)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Fernando Rodríguez-Artalejo (F)

IMDEA Food Institute, CEI UAM+CSIC, Madrid, Spain.
Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid and CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Cardiovascular and Nutritional Epidemiology Group, IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), Madrid, Spain.

Frederick K Ho (FK)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Jill P Pell (JP)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

David Martínez-Gómez (D)

IMDEA Food Institute, CEI UAM+CSIC, Madrid, Spain.
Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid and CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Carlos Celis-Morales (C)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Laboratorio de Rendimiento Humano, Grupo de Estudio en Educación, Actividad Física y Salud (GEEAFyS), Universidad Católica del Maule, Talca, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH